{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:38:18Z","timestamp":1790318298541,"version":"4.1.0"},"publisher-location":"Cham","reference-count":242,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319997155","type":"print"},{"value":"9783319997162","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-319-99716-2_2","type":"book-chapter","created":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T11:33:57Z","timestamp":1546169637000},"page":"31-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma"],"prefix":"10.1007","author":[{"given":"Javeed","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"McKeithan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"issue":"1","key":"2_CR1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR et al (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 13(1):140\u2013149","journal-title":"Ann Oncol"},{"issue":"20","key":"2_CR2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"key":"2_CR3","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn"},{"issue":"1","key":"2_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5581\/1516-8484.20120013","volume":"34","author":"M Bellei","year":"2012","unstructured":"Bellei M, Chiattone CS, Luminari S et al (2012) T-cell lymphomas in South america and europe. Rev Bras Hematol Hemoter. 34(1):42\u201347","journal-title":"Rev Bras Hematol Hemoter."},{"issue":"5","key":"2_CR5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3109\/10428194.2012.729056","volume":"54","author":"N Arora","year":"2013","unstructured":"Arora N, Manipadam MT, Nair S (2013) Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature. Leuk Lymphoma 54(5):1004\u20131011","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00277-015-2543-4","volume":"95","author":"AM Perry","year":"2016","unstructured":"Perry AM, Diebold J, Nathwani BN et al (2016) Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project. Ann Hematol 95(2):245\u2013251","journal-title":"Ann Hematol"},{"issue":"25","key":"2_CR7","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"International peripheral T-cell and natural killer\/t-cell lymphoma study","year":"2008","unstructured":"International peripheral T-cell and natural killer\/t-cell lymphoma study (2008) pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol"},{"issue":"10","key":"2_CR8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","volume":"101","author":"AM Perry","year":"2016","unstructured":"Perry AM, Diebold J, Nathwani BN et al (2016) Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project. Haematologica 101(10):1244\u20131250","journal-title":"Haematologica"},{"issue":"9","key":"2_CR9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","volume":"34","author":"SV Adams","year":"2016","unstructured":"Adams SV, Newcomb PA, Shustov AR (2016) Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States. J Clin Oncol 34(9):963\u2013971","journal-title":"J Clin Oncol"},{"key":"2_CR10","unstructured":"Wang. SS, Vose. JM (2103) Epidemiology and Prognosis of T-Cell Lymphoma. Springer Science, New York"},{"issue":"19","key":"2_CR11","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C et al (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123(19):2915\u20132923","journal-title":"Blood"},{"issue":"5","key":"2_CR12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC et al (2010) Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115(5):1026\u20131036","journal-title":"Blood"},{"issue":"2","key":"2_CR13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","volume":"25","author":"J Iqbal","year":"2011","unstructured":"Iqbal J, Weisenburger DD, Chowdhury A et al (2011) Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia 25(2):348\u2013358","journal-title":"Leukemia"},{"issue":"3","key":"2_CR14","doi-asserted-by":"crossref","first-page":"e92585","DOI":"10.1371\/journal.pone.0092585","volume":"9","author":"B Xu","year":"2014","unstructured":"Xu B, Liu P (2014) No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases. PLoS ONE 9(3):e92585","journal-title":"PLoS ONE"},{"key":"2_CR15","doi-asserted-by":"crossref","unstructured":"Croziera JA,, Shera T, Yangb D et al (2015) Persistent disparities among patients with T-cell Non-Hodgkin Lymphomas and B-cell Diffuse Large Cell Lymphomas over 40\u00a0years: a seer database review. Clin Lymphoma Myeloma Leukemia","DOI":"10.1016\/j.clml.2015.06.005"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/bcj.2014.34","volume":"4","author":"R Briski","year":"2014","unstructured":"Briski R, Feldman AL, Bailey NG et al (2014) The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas. Blood Cancer J. 4:e214","journal-title":"Blood Cancer J."},{"key":"2_CR17","unstructured":"Swerdlow SH, Elias Campo, Harris NL et al (2017) WHO classification of Tumours of the Haematopoitic and Lymphoid Tissues. Lyon, IARC Press, France"},{"issue":"5","key":"2_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri798","volume":"2","author":"RN Germain","year":"2002","unstructured":"Germain RN (2002) T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol 2(5):309\u2013322","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2_CR19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ni965","volume":"4","author":"CH Martin","year":"2003","unstructured":"Martin CH, Aifantis I, Scimone ML et al (2003) Efficient thymic immigration of B220+\u2009lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol 4(9):866\u2013873","journal-title":"Nat Immunol"},{"issue":"5","key":"2_CR20","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/eji.201344046","volume":"44","author":"M Poltorak","year":"2014","unstructured":"Poltorak M, Meinert I, Stone JC, Schraven B, Simeoni L (2014) Sos1 regulates sustained TCR-mediated Erk activation. Eur J Immunol 44(5):1535\u20131540","journal-title":"Eur J Immunol"},{"issue":"9","key":"2_CR21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.20022112","volume":"197","author":"D Filipp","year":"2003","unstructured":"Filipp D, Zhang J, Leung BL et al (2003) Regulation of Fyn through translocation of activated Lck into lipid rafts. J Exp Med 197(9):1221\u20131227","journal-title":"J Exp Med"},{"issue":"41","key":"2_CR22","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1073\/pnas.0406168101","volume":"101","author":"K Sugie","year":"2004","unstructured":"Sugie K, Jeon MS, Grey HM (2004) Activation of naive CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling. Proc Natl Acad Sci U S A. 101(41):14859\u201314864","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2_CR23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.immuni.2004.09.012","volume":"21","author":"JL Cannons","year":"2004","unstructured":"Cannons JL, Yu LJ, Hill B et al (2004) SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 21(5):693\u2013706","journal-title":"Immunity"},{"issue":"2","key":"2_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2010.01.010","volume":"32","author":"JL Cannons","year":"2010","unstructured":"Cannons JL, Qi H, Lu KT et al (2010) Optimal germinal center responses require a multistage T cell: B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32(2):253\u2013265","journal-title":"Immunity"},{"issue":"2","key":"2_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ncb919","volume":"5","author":"S Latour","year":"2003","unstructured":"Latour S, Roncagalli R, Chen R et al (2003) Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat Cell Biol 5(2):149\u2013154","journal-title":"Nat Cell Biol"},{"issue":"6","key":"2_CR26","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.4049\/jimmunol.169.6.2813","volume":"169","author":"K Yasuda","year":"2002","unstructured":"Yasuda K, Nagafuku M, Shima T et al (2002) Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein\/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells. J Immunol. 169(6):2813\u20132817","journal-title":"J Immunol."},{"issue":"11","key":"2_CR27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ni.2120","volume":"12","author":"KF Kong","year":"2011","unstructured":"Kong KF, Yokosuka T, Canonigo-Balancio AJ, Isakov N, Saito T, Altman A (2011) A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat Immunol 12(11):1105\u20131112","journal-title":"Nat Immunol"},{"issue":"1","key":"2_CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14348\/molcells.2017.2236","volume":"40","author":"JA Kang","year":"2017","unstructured":"Kang JA, Choi H, Yang T, Cho SK, Park ZY, Park SG (2017) PKCtheta-Mediated PDK1 Phosphorylation Enhances T Cell Activation by Increasing PDK1 Stability. Mol Cells 40(1):37\u201344","journal-title":"Mol Cells"},{"issue":"6","key":"2_CR29","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.molcel.2013.08.032","volume":"51","author":"Q Qiao","year":"2013","unstructured":"Qiao Q, Yang C, Zheng C et al (2013) Structural architecture of the CARMA1\/Bcl10\/MALT1 signalosome: nucleation-induced filamentous assembly. Mol Cell 51(6):766\u2013779","journal-title":"Mol Cell"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1146\/annurev.immunol.20.100301.064807","volume":"20","author":"N Isakov","year":"2002","unstructured":"Isakov N, Altman A (2002) Protein kinase C(theta) in T cell activation. Annu Rev Immunol 20:761\u2013794","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"2_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/2040620713519729","volume":"5","author":"A Gazzola","year":"2014","unstructured":"Gazzola A, Mannu C, Rossi M et al (2014) The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies. Ther Adv Hematol. 5(2):35\u201347","journal-title":"Ther Adv Hematol."},{"issue":"12","key":"2_CR32","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17(12):2257\u20132317","journal-title":"Leukemia"},{"issue":"11","key":"2_CR33","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/sj.leu.2403081","volume":"17","author":"T Szczepanski","year":"2003","unstructured":"Szczepanski T, van der Velden VH, Raff T et al (2003) Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia 17(11):2149\u20132156","journal-title":"Leukemia"},{"issue":"2","key":"2_CR34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.blre.2015.08.002","volume":"30","author":"J Iqbal","year":"2016","unstructured":"Iqbal J, Naushad H, Bi C et al (2016) Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? Blood Rev 30(2):73\u201388","journal-title":"Blood Rev"},{"issue":"2","key":"2_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2015.08.003","volume":"30","author":"J Iqbal","year":"2016","unstructured":"Iqbal J, Wilcox R, Naushad H et al (2016) Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? Blood Rev 30(2):89\u2013100","journal-title":"Blood Rev"},{"issue":"7","key":"2_CR36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","volume":"125","author":"J Iqbal","year":"2015","unstructured":"Iqbal J, Shen Y, Huang X et al (2015) Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood 125(7):1137\u20131145","journal-title":"Blood"},{"issue":"21","key":"2_CR37","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2011-07-370122","volume":"119","author":"J Iqbal","year":"2012","unstructured":"Iqbal J, Shen Y, Liu Y et al (2012) Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. Blood 119(21):4939\u20134948","journal-title":"Blood"},{"issue":"12","key":"2_CR38","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2012-08-447375","volume":"122","author":"C Liu","year":"2013","unstructured":"Liu C, Iqbal J, Teruya-Feldstein J et al (2013) MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 122(12):2083\u20132092","journal-title":"Blood"},{"issue":"11","key":"2_CR39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","volume":"123","author":"A Bouska","year":"2014","unstructured":"Bouska A, McKeithan TW, Deffenbacher KE et al (2014) Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood 123(11):1681\u20131690","journal-title":"Blood"},{"issue":"1","key":"2_CR40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/leu.2016.175","volume":"31","author":"A Bouska","year":"2017","unstructured":"Bouska A, Zhang W, Gong Q et al (2017) Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia 31(1):83\u201391","journal-title":"Leukemia"},{"issue":"8","key":"2_CR41","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","volume":"119","author":"RA Cairns","year":"2012","unstructured":"Cairns RA, Iqbal J, Lemonnier F et al (2012) IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119(8):1901\u20131903","journal-title":"Blood"},{"issue":"12","key":"2_CR42","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-13-1597","volume":"20","author":"S Guo","year":"2014","unstructured":"Guo S, Chan JK, Iqbal J et al (2014) EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations. Clin Cancer Res 20(12):3078\u20133086","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2_CR43","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-14-1216","volume":"21","author":"C Kucuk","year":"2015","unstructured":"Kucuk C, Hu X, Jiang B et al (2015) Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clin Cancer Res 21(7):1699\u20131711","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","volume":"7","author":"M McKinney","year":"2017","unstructured":"McKinney M, Moffitt AB, Gaulard P et al (2017) The Genetic Basis of Hepatosplenic T-cell Lymphoma. Cancer Discov 7(4):369\u2013379","journal-title":"Cancer Discov"},{"key":"2_CR45","doi-asserted-by":"crossref","unstructured":"Laurent C et al (2017) J Clinic Oncol 35(18):2008\u20132017","DOI":"10.1200\/JCO.2016.71.2083"},{"key":"2_CR46","doi-asserted-by":"crossref","unstructured":"Weisenburger et al (2011) Blood, 117:3402\u20133408","DOI":"10.1182\/blood-2010-09-310342"},{"key":"2_CR47","doi-asserted-by":"crossref","unstructured":"Bowen et al (2014) Bristish J Hematol 166:202\u2013208","DOI":"10.1111\/bjh.12880"},{"issue":"11","key":"2_CR48","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L Leval de","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C et al (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109(11):4952\u20134963","journal-title":"Blood"},{"issue":"3","key":"2_CR49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.781","volume":"24","author":"B Martinez-Delgado","year":"2006","unstructured":"Martinez-Delgado B (2006) Peripheral T-cell lymphoma gene expression profiles. Hematol Oncol 24(3):113\u2013119","journal-title":"Hematol Oncol"},{"issue":"3","key":"2_CR50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","volume":"117","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A et al (2007) Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest. 117(3):823\u2013834","journal-title":"J Clin Invest."},{"issue":"22","key":"2_CR51","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","volume":"25","author":"M Cuadros","year":"2007","unstructured":"Cuadros M, Dave SS, Jaffe ES et al (2007) Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 25(22):3321\u20133329","journal-title":"J Clin Oncol"},{"issue":"12","key":"2_CR52","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","volume":"19","author":"B Martinez-Delgado","year":"2005","unstructured":"Martinez-Delgado B, Cuadros M, Honrado E et al (2005) Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia 19(12):2254\u20132263","journal-title":"Leukemia"},{"issue":"24","key":"2_CR53","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","volume":"31","author":"PP Piccaluga","year":"2013","unstructured":"Piccaluga PP, Fuligni F, De Leo A et al (2013) Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 31(24):3019\u20133025","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology."},{"issue":"10","key":"2_CR54","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","volume":"25","author":"B Ballester","year":"2006","unstructured":"Ballester B, Ramuz O, Gisselbrecht C et al (2006) Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 25(10):1560\u20131570","journal-title":"Oncogene"},{"issue":"5969","key":"2_CR55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","volume":"327","author":"JJ O\u2019Shea","year":"2010","unstructured":"O\u2019Shea JJ, Paul WE (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+\u2009T cells. Science 327(5969):1098\u20131102","journal-title":"Science"},{"issue":"19","key":"2_CR56","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","volume":"123","author":"T. Wang","year":"2014","unstructured":"Wang T, Feldman AL, Wada DA et al (2014) GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood 123(19):3007\u20133015","journal-title":"Blood"},{"key":"2_CR57","doi-asserted-by":"crossref","unstructured":"Heavican TB, Yu J, Bouska A, Greiner TC, Lachel CM, Wang C, Dave BJ, Amador CC, Fu K, Vose JM, Weisenburger DD, Gascoyne RD, Hartmann S, Pedersen MBJ, Wilcox R, Teh BT, Lim ST, Ong CK, Seto M, Berger F, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d\u2019Amore FA, Inghirami G, Bertoni F, Staudt L, McKeithan TW, Pileri SA, Chan WC, Iqbal J (2016) Molecular subgroups of peripheral T-cell lymphoma evolve by distinct genetic pathways. In: 58th ASH Annual Meeting and Exposition, San Diego, CA","DOI":"10.1182\/blood.V128.22.4096.4096"},{"issue":"1","key":"2_CR58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/leu.2014.261","volume":"29","author":"JH Schatz","year":"2015","unstructured":"Schatz JH, Horwitz SM, Teruya-Feldstein J et al (2015) Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis. Leukemia 29(1):237\u2013241","journal-title":"Leukemia"},{"issue":"4","key":"2_CR59","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1073\/pnas.1608839114","volume":"114","author":"F Abate","year":"2017","unstructured":"Abate F, da Silva-Almeida AC, Zairis S et al (2017) Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc Natl Acad Sci U S A. 114(4):764\u2013769","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"2_CR60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo HY, Sung MK, Lee SH et al (2014) A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet 46(4):371\u2013375","journal-title":"Nat Genet"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/bcj.2014.78","volume":"4","author":"MA Laginestra","year":"2014","unstructured":"Laginestra MA, Piccaluga PP, Fuligni F et al (2014) Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified. Blood Cancer J. 4:259","journal-title":"Blood Cancer J."},{"issue":"4","key":"2_CR62","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E et al (2017) Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica 102(4):e148\u2013e151","journal-title":"Haematologica"},{"issue":"22","key":"2_CR63","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"Pier Paolo Piccaluga","year":"2007","unstructured":"Piccaluga et al (2007) Cancer Res 15, 67(22):10703\u201310710","journal-title":"Cancer Research"},{"issue":"4","key":"2_CR64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"Shane Crotty","year":"2014","unstructured":"Crotty S (2014) Immunity 41(4):529\u2013542","journal-title":"Immunity"},{"issue":"4","key":"2_CR65","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ni.1704","volume":"10","author":"N Fazilleau","year":"2009","unstructured":"Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG (2009) The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol 10(4):375\u2013384","journal-title":"Nat Immunol"},{"issue":"4","key":"2_CR66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1084\/jem.20141380","volume":"212","author":"K Hatzi","year":"2015","unstructured":"Hatzi K, Nance JP, Kroenke MA et al (2015) BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms. J Exp Med 212(4):539\u2013553","journal-title":"J Exp Med"},{"issue":"4","key":"2_CR67","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","volume":"30","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Boye K, Martin N et al (2006) Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 30(4):490\u2013494","journal-title":"Am J Surg Pathol"},{"key":"2_CR68","unstructured":"Miysohi et al (2012) Am J Clin Pathol 137(6):879\u201389"},{"issue":"2","key":"2_CR69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2559.2011.04022.x","volume":"60","author":"B Bisig","year":"2012","unstructured":"Bisig B, Thielen C, Herens C et al (2012) c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis. Histopathology 60(2):371\u2013376","journal-title":"Histopathology"},{"issue":"11","key":"2_CR70","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/PAS.0b013e318054dbcf","volume":"31","author":"YI Murakami","year":"2007","unstructured":"Murakami YI, Yatabe Y, Sakaguchi T et al (2007) c-Maf expression in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 31(11):1695\u20131702","journal-title":"Am J Surg Pathol"},{"key":"2_CR71","doi-asserted-by":"crossref","unstructured":"Iqbal J et al (2007) Leukemia 21(11):2332\u20132343","DOI":"10.1038\/sj.leu.2404856"},{"issue":"5","key":"2_CR72","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC et al (2010) Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115(5):1026\u20131036","journal-title":"Blood"},{"issue":"4","key":"2_CR73","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","volume":"106","author":"KL Grogg","year":"2005","unstructured":"Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A (2005) Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood 106(4):1501\u20131502","journal-title":"Blood"},{"issue":"2","key":"2_CR74","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood.V83.2.505.505","volume":"83","author":"B Schlegelberger","year":"1994","unstructured":"Schlegelberger B, Himmler A, Godde E, Grote W, Feller AC, Lennert K (1994) Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 83(2):505\u2013511","journal-title":"Blood"},{"issue":"4","key":"2_CR75","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.2008.07042.x","volume":"141","author":"M Nelson","year":"2008","unstructured":"Nelson M, Horsman DE, Weisenburger DD et al (2008) Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma. Br J Haematol 141(4):461\u2013469","journal-title":"Br J Haematol"},{"issue":"1","key":"2_CR76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-4608(99)00151-X","volume":"117","author":"S Lepretre","year":"2000","unstructured":"Lepretre S, Buchonnet G, Stamatoullas A et al (2000) Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet 117(1):71\u201379","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"2_CR77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1987.tb01326.x","volume":"66","author":"T Lakkala-Paranko","year":"1987","unstructured":"Lakkala-Paranko T, Franssila K, Lappalainen K et al (1987) Chromosome abnormalities in peripheral T-cell lymphoma. Br J Haematol 66(4):451\u2013460","journal-title":"Br J Haematol"},{"issue":"7","key":"2_CR78","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","volume":"120","author":"F Lemonnier","year":"2012","unstructured":"Lemonnier F, Couronne L, Parrens M et al (2012) Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120(7):1466\u20131469","journal-title":"Blood"},{"issue":"2","key":"2_CR79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K et al (2014) Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet 46(2):171\u2013175","journal-title":"Nat Genet"},{"issue":"9","key":"2_CR80","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA et al (2014) A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123(9):1293\u20131296","journal-title":"Blood"},{"issue":"2","key":"2_CR81","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.stem.2011.07.010","volume":"9","author":"Meelad\u00a0M. Dawlaty","year":"2011","unstructured":"Dawlaty MM, Ganz K, Powell BE, et al Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 9(2):166\u2013175","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2_CR82","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.devcel.2012.12.015","volume":"24","author":"Meelad\u00a0M. Dawlaty","year":"2013","unstructured":"Dawlaty MM, Breiling A, Le T, et al. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev Cell 24(3):310\u2013323","journal-title":"Developmental Cell"},{"issue":"23","key":"2_CR83","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1101\/gad.179184.111","volume":"25","author":"H Wu","year":"2011","unstructured":"Wu H, Zhang Y (2011) Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 25(23):2436\u20132452","journal-title":"Genes Dev"},{"issue":"5","key":"2_CR84","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ygeno.2014.08.012","volume":"104","author":"PW Hill","year":"2014","unstructured":"Hill PW, Amouroux R, Hajkova P (2014) DNA demethylation, Tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story. Genomics 104(5):324\u2013333","journal-title":"Genomics"},{"issue":"6127","key":"2_CR85","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1231677","volume":"339","author":"JA Losman","year":"2013","unstructured":"Losman JA, Looper RE, Koivunen P et al (2013) (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339(6127):1621\u20131625","journal-title":"Science"},{"issue":"7390","key":"2_CR86","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","volume":"483","author":"P Koivunen","year":"2012","unstructured":"Koivunen P, Lee S, Duncan CG et al (2012) Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483(7390):484\u2013488","journal-title":"Nature"},{"issue":"17","key":"2_CR87","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","volume":"118","author":"Z Li","year":"2011","unstructured":"Li Z, Cai X, Cai CL et al (2011) Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118(17):4509\u20134518","journal-title":"Blood"},{"issue":"7413","key":"2_CR88","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature11323","volume":"488","author":"M Sasaki","year":"2012","unstructured":"Sasaki M, Knobbe CB, Munger JC et al (2012) IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488(7413):656\u2013659","journal-title":"Nature"},{"issue":"5","key":"2_CR89","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1101\/gad.231233.113","volume":"28","author":"EA Akbay","year":"2014","unstructured":"Akbay EA, Moslehi J, Christensen CL et al (2014) D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice. Genes Dev 28(5):479\u2013490","journal-title":"Genes Dev"},{"issue":"18","key":"2_CR90","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1101\/gad.226613.113","volume":"27","author":"C Chen","year":"2013","unstructured":"Chen C, Liu Y, Lu C et al (2013) Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. Genes Dev 27(18):1974\u20131985","journal-title":"Genes Dev"},{"key":"2_CR91","doi-asserted-by":"crossref","unstructured":"Xu W, Yang H, Liu Y et al Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1):17\u201330","DOI":"10.1016\/j.ccr.2010.12.014"},{"issue":"2","key":"2_CR92","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","volume":"46","author":"Teresa Palomero","year":"2014","unstructured":"Palomero T, Couronne L, Khiabanian H et al Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nature genetics 46(2):166\u2013170","journal-title":"Nature Genetics"},{"issue":"5","key":"2_CR93","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","volume":"127","author":"Y Nagata","year":"2016","unstructured":"Nagata Y, Kontani K, Enami T et al (2016) Variegated RHOA mutations in adult T-cell leukemia\/lymphoma. Blood 127(5):596\u2013604","journal-title":"Blood"},{"issue":"4","key":"2_CR94","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"Hae Yong Yoo","year":"2014","unstructured":"Yoo HY, Sung MK, Lee SH, et al A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nature genetics 46(4):371\u2013375","journal-title":"Nature Genetics"},{"issue":"18","key":"2_CR95","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2013-01-451781","volume":"121","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab O, Levine RL (2013) Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood 121(18):3563\u20133572","journal-title":"Blood"},{"issue":"21","key":"2_CR96","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood.V124.21.1681.1681","volume":"124","author":"J Rohr","year":"2014","unstructured":"Rohr J, Guo S, Hu D et al (2014) CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression. Blood 124(21):1681\u20131681","journal-title":"Blood"},{"key":"2_CR97","doi-asserted-by":"crossref","unstructured":"Rohr J, Guo S, Huo J et al (2015) Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. Leukemia","DOI":"10.1038\/leu.2015.357"},{"issue":"15","key":"2_CR98","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","volume":"126","author":"C Wang","year":"2015","unstructured":"Wang C, McKeithan TW, Gong Q et al (2015) IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood 126(15):1741\u20131752","journal-title":"Blood"},{"issue":"24","key":"2_CR99","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1182\/blood-2013-03-493197","volume":"121","author":"C. D. DiNardo","year":"2013","unstructured":"DiNardo CD, Propert KJ, Loren AW et al Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood 121(24):4917\u20134924","journal-title":"Blood"},{"key":"2_CR100","doi-asserted-by":"crossref","unstructured":"Cheminant M, Bruneau J, Kosmider O et al (2014) Efficacy of 5-Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma. Br J Haematol","DOI":"10.1111\/bjh.13170"},{"key":"2_CR101","doi-asserted-by":"crossref","unstructured":"Pro B, Horwitz SM, Prince HM et al (2016) Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma. Hematol Oncol","DOI":"10.1002\/hon.2320"},{"issue":"12","key":"2_CR102","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H","volume":"30","author":"A Borroto","year":"2000","unstructured":"Borroto A, Gil D, Delgado P et al (2000) Rho regulates T cell receptor ITAM-induced lymphocyte spreading in an integrin-independent manner. Eur J Immunol 30(12):3403\u20133410","journal-title":"Eur J Immunol"},{"issue":"1-2","key":"2_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2011.12.003","volume":"142","author":"Pablo Rougerie","year":"2012","unstructured":"Rougerie P, Delon J Rho GTPases: masters of T lymphocyte migration and activation. Immunol Lett 142(1\u20132):1-13","journal-title":"Immunology Letters"},{"issue":"1","key":"2_CR104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.onc.1203259","volume":"19","author":"SC Cleverley","year":"2000","unstructured":"Cleverley SC, Costello PS, Henning SW, Cantrell DA (2000) Loss of Rho function in the thymus is accompanied by the development of thymic lymphoma. Oncogene 19(1):13\u201320","journal-title":"Oncogene"},{"key":"2_CR105","doi-asserted-by":"crossref","unstructured":"Cortes JR, Ambesi-Impiombato A, Couronne L, Kim CS, West Z, Belver L, da Silva Almeida AC, Bhagat G, Bernard OA, Ferrando AA, PalomeroT (2016) Role and Mechanisms of Rhoa G17\u00a0V in the Pathogenesis of AITL. ASH Meeting, San Diego","DOI":"10.1182\/blood.V128.22.608.608"},{"issue":"4","key":"2_CR106","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ncb1236","volume":"7","author":"Z Li","year":"2005","unstructured":"Li Z, Dong X, Wang Z et al (2005) Regulation of PTEN by Rho small GTPases. Nat Cell Biol 7(4):399\u2013404","journal-title":"Nat Cell Biol"},{"issue":"5196","key":"2_CR107","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.267.5196.316-b","volume":"267","author":"SW Morris","year":"1995","unstructured":"Morris SW, Kirstein MN, Valentine MB et al (1995) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 267(5196):316\u2013317","journal-title":"Science"},{"issue":"2","key":"2_CR108","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1990.tb02560.x","volume":"74","author":"DY Mason","year":"1990","unstructured":"Mason DY, Bastard C, Rimokh R et al (1990) CD30-positive large cell lymphomas (\u2018Ki-1 lymphoma\u2019) are associated with a chromosomal translocation involving 5q35. Br J Haematol 74(2):161\u2013168","journal-title":"Br J Haematol"},{"issue":"5151","key":"2_CR109","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB et al (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 263(5151):1281\u20131284","journal-title":"Science"},{"issue":"1","key":"2_CR110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2141.1989.tb06270.x","volume":"71","author":"R Rimokh","year":"1989","unstructured":"Rimokh R, Magaud JP, Berger F et al (1989) A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (\u2018Ki-1 lymphoma\u2019). Br J Haematol 71(1):31\u201336","journal-title":"Br J Haematol"},{"issue":"6","key":"2_CR111","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","volume":"120","author":"L Agnelli","year":"2012","unstructured":"Agnelli L, Mereu E, Pellegrino E et al (2012) Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood 120(6):1274\u20131281","journal-title":"Blood"},{"issue":"12","key":"2_CR112","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1172\/JCI29401","volume":"116","author":"R Piva","year":"2006","unstructured":"Piva R, Pellegrino E, Mattioli M et al (2006) Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest. 116(12):3171\u20133182","journal-title":"J Clin Invest."},{"issue":"26","key":"2_CR113","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1182\/blood-2011-05-354654","volume":"118","author":"H Matsuyama","year":"2011","unstructured":"Matsuyama H, Suzuki HI, Nishimori H et al (2011) miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 118(26):6881\u20136892","journal-title":"Blood"},{"key":"2_CR114","doi-asserted-by":"crossref","unstructured":"Abate F, Todaro M, van der Krogt JA et al (2014) A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation. Leukemia","DOI":"10.1038\/leu.2014.347"},{"issue":"9","key":"2_CR115","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW et al (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124(9):1473\u20131480","journal-title":"Blood"},{"issue":"4","key":"2_CR116","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","volume":"27","author":"R Crescenzo","year":"2015","unstructured":"Crescenzo R, Abate F, Lasorsa E et al (2015) Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 27(4):516\u2013532","journal-title":"Cancer Cell"},{"issue":"1","key":"2_CR117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","volume":"8","author":"R Chiarle","year":"2008","unstructured":"Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G (2008) The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer 8(1):11\u201323","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2_CR118","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3324\/haematol.2013.088286","volume":"99","author":"E Spaccarotella","year":"2014","unstructured":"Spaccarotella E, Pellegrino E, Ferracin M et al (2014) STAT3-mediated activation of microRNA cluster 17\u201392 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica 99(1):116\u2013124","journal-title":"Haematologica"},{"issue":"37","key":"2_CR119","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1073\/pnas.1009719107","volume":"107","author":"O Merkel","year":"2010","unstructured":"Merkel O, Hamacher F, Laimer D et al (2010) Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+\u2009and ALK- anaplastic large-cell lymphoma. Proc Natl Acad Sci U S A. 107(37):16228\u201316233","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2_CR120","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/JVI.75.5.2185-2193.2001","volume":"75","author":"T Portis","year":"2001","unstructured":"Portis T, Grossman WJ, Harding JC, Hess JL, Ratner L (2001) Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model. J Virol 75(5):2185\u20132193","journal-title":"J Virol"},{"issue":"21","key":"2_CR121","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1158\/0008-5472.CAN-13-3564","volume":"74","author":"C Vernin","year":"2014","unstructured":"Vernin C, Thenoz M, Pinatel C et al (2014) HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs. Cancer Res 74(21):6082\u20136093","journal-title":"Cancer Res"},{"issue":"2","key":"2_CR122","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.18632\/oncotarget.6424","volume":"7","author":"DG Wright","year":"2016","unstructured":"Wright DG, Marchal C, Hoang K et al (2016) Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300\/CBP and HBO1. Oncotarget. 7(2):1687\u20131706","journal-title":"Oncotarget."},{"issue":"3","key":"2_CR123","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","volume":"105","author":"H Sasaki","year":"2005","unstructured":"Sasaki H, Nishikata I, Shiraga T et al (2005) Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105(3):1204\u20131213","journal-title":"Blood"},{"key":"2_CR124","doi-asserted-by":"crossref","unstructured":"Pise-Masison CA, Radonovich M, Dohoney K et al (2009) Gene expression profiling of ATL patients: compilation of disease related genes and evidence for TCF-4 involvement in BIRC5 gene expression and cell viability. Blood","DOI":"10.1182\/blood-2008-08-175901"},{"issue":"10","key":"2_CR125","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.3324\/haematol.2016.146977","volume":"101","author":"P. L. Zinzani","year":"2016","unstructured":"Zinzani et al (2016) Haematologica 101(10):e407\u2013410","journal-title":"Haematologica"},{"key":"2_CR126","doi-asserted-by":"crossref","unstructured":"Ogura M et al (2014) J Clin Oncol 10, 32(11):1157\u20131163","DOI":"10.1111\/ajco.12282"},{"issue":"11","key":"2_CR127","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A et al (2015) Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet 47(11):1304\u20131315","journal-title":"Nat Genet"},{"issue":"5","key":"2_CR128","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","volume":"99","author":"O Yoshie","year":"2002","unstructured":"Yoshie O, Fujisawa R, Nakayama T et al (2002) Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 99(5):1505\u20131511","journal-title":"Blood"},{"issue":"10","key":"2_CR129","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/10428190600775599","volume":"47","author":"H Harasawa","year":"2006","unstructured":"Harasawa H, Yamada Y, Hieshima K et al (2006) Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia\/lymphoma. Leuk Lymphoma 47(10):2163\u20132173","journal-title":"Leuk Lymphoma"},{"issue":"7601","key":"2_CR130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature17947","volume":"533","author":"J Li","year":"2016","unstructured":"Li J, Lu E, Yi T, Cyster JG (2016) EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells. Nature 533(7601):110\u2013114","journal-title":"Nature"},{"issue":"6","key":"2_CR131","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1046\/j.1365-2141.2003.04216.x","volume":"120","author":"K Fujii","year":"2003","unstructured":"Fujii K, Ishimaru F, Nakase K et al (2003) Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia\/lymphoma. Br J Haematol 120(6):986\u2013989","journal-title":"Br J Haematol"},{"issue":"5","key":"2_CR132","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2005-01-031930","volume":"109","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Swindle CS, Bates JT, Ko R, Cotta CV, Klug CA (2007) Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. Blood 109(5):2190\u20132197","journal-title":"Blood"},{"issue":"1","key":"2_CR133","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2353\/ajpath.2010.090236","volume":"176","author":"H Sato","year":"2010","unstructured":"Sato H, Oka T, Shinnou Y et al (2010) Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia\/lymphoma. Am J Pathol 176(1):402\u2013415","journal-title":"Am J Pathol"},{"issue":"4","key":"2_CR134","first-page":"1043","volume":"60","author":"K Nosaka","year":"2000","unstructured":"Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M (2000) Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res 60(4):1043\u20131048","journal-title":"Cancer Res"},{"issue":"14","key":"2_CR135","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","volume":"127","author":"D Fujikawa","year":"2016","unstructured":"Fujikawa D, Nakagawa S, Hori M et al (2016) Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood 127(14):1790\u20131802","journal-title":"Blood"},{"key":"2_CR136","doi-asserted-by":"crossref","unstructured":"Krejsgaard T, Lindahl LM, Mongan NP et al (2016) Malignant inflammation in cutaneous T-cell lymphoma\u2014a hostile takeover. Seminars in immunopathology","DOI":"10.1007\/s00281-016-0594-9"},{"issue":"3","key":"2_CR137","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2010.03.044","volume":"64","author":"Edgar S. Macias","year":"2011","unstructured":"Macias ES, Pereira FA, Rietkerk W, Safai B (2011) Superantigens in dermatology. J Am Acad Dermatol 64(3):455\u2013472; Quiz 473\u2013454","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"16","key":"2_CR138","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-14-0077","volume":"20","author":"H Suga","year":"2014","unstructured":"Suga H, Sugaya M, Miyagaki T et al (2014) Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma. Clin Cancer Res 20(16):4339\u20134348","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2_CR139","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/jid.2014.284","volume":"135","author":"C Thode","year":"2015","unstructured":"Thode C, Woetmann A, Wandall HH et al (2015) Malignant T cells secrete galectins and induce epidermal hyperproliferation and disorganized stratification in a skin model of cutaneous T-cell lymphoma. J Invest Dermatol. 135(1):238\u2013246","journal-title":"J Invest Dermatol."},{"issue":"1","key":"2_CR140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","volume":"92","author":"U Dobbeling","year":"1998","unstructured":"Dobbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G (1998) Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood 92(1):252\u2013258","journal-title":"Blood"},{"issue":"5","key":"2_CR141","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1046\/j.1365-2133.2001.04192.x","volume":"144","author":"S Leroy","year":"2001","unstructured":"Leroy S, Dubois S, Tenaud I et al (2001) Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). The British journal of dermatology. 144(5):1016\u20131023","journal-title":"The British journal of dermatology."},{"issue":"21","key":"2_CR142","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","volume":"13","author":"E Netchiporouk","year":"2014","unstructured":"Netchiporouk E, Litvinov IV, Moreau L, Gilbert M, Sasseville D, Duvic M (2014) Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Cell Cycle 13(21):3331\u20133335","journal-title":"Cell Cycle"},{"issue":"9","key":"2_CR143","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/2159-8290.CD-15-1297","volume":"6","author":"A Mishra","year":"2016","unstructured":"Mishra A, La Perle K, Kwiatkowski S et al (2016) Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma. Cancer Discov 6(9):986\u20131005","journal-title":"Cancer Discov"},{"issue":"2","key":"2_CR144","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/leu.2011.198","volume":"26","author":"RC McKenzie","year":"2012","unstructured":"McKenzie RC, Jones CL, Tosi I, Caesar JA, Whittaker SJ, Mitchell TJ (2012) Constitutive activation of STAT3 in Sezary syndrome is independent of SHP-1. Leukemia 26(2):323\u2013331","journal-title":"Leukemia"},{"issue":"2","key":"2_CR145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/jid.2011.293","volume":"132","author":"L Fits van der","year":"2012","unstructured":"van der Fits L, Out-Luiting JJ, van Leeuwen MA et al (2012) Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sezary syndrome. J Invest Dermatol. 132(2):440\u2013447","journal-title":"J Invest Dermatol."},{"issue":"21","key":"2_CR146","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-16-0992","volume":"76","author":"N Takahashi","year":"2016","unstructured":"Takahashi N, Sugaya M, Suga H et al (2016) Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma. Cancer Res 76(21):6241\u20136252","journal-title":"Cancer Res"},{"issue":"2","key":"2_CR147","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/10428194.2014.919634","volume":"56","author":"M Tuzova","year":"2015","unstructured":"Tuzova M, Richmond J, Wolpowitz D et al (2015) CCR4+\u2009T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16. Leuk Lymphoma 56(2):440\u2013449","journal-title":"Leuk Lymphoma"},{"issue":"18","key":"2_CR148","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","volume":"125","author":"LJ Geskin","year":"2015","unstructured":"Geskin LJ, Viragova S, Stolz DB, Fuschiotti P (2015) Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood 125(18):2798\u20132805","journal-title":"Blood"},{"issue":"9","key":"2_CR149","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2326-6066.CIR-13-0199-T","volume":"2","author":"H Ohmatsu","year":"2014","unstructured":"Ohmatsu H, Humme D, Gulati N et al (2014) IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization. Cancer Immunol Res 2(9):890\u2013900","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"2_CR150","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/jid.2013.488","volume":"134","author":"H Suga","year":"2014","unstructured":"Suga H, Sugaya M, Miyagaki T et al (2014) The role of IL-32 in cutaneous T-cell lymphoma. J Invest Dermatol. 134(5):1428\u20131435","journal-title":"J Invest Dermatol."},{"issue":"17","key":"2_CR151","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.18632\/oncotarget.3837","volume":"6","author":"B Lauenborg","year":"2015","unstructured":"Lauenborg B, Christensen L, Ralfkiaer U et al (2015) Malignant T cells express lymphotoxin alpha and drive endothelial activation in cutaneous T cell lymphoma. Oncotarget. 6(17):15235\u201315249","journal-title":"Oncotarget."},{"issue":"8","key":"2_CR152","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood-2012-10-460535","volume":"121","author":"L Michel","year":"2013","unstructured":"Michel L, Jean-Louis F, Begue E, Bensussan A, Bagot M (2013) Use of PLS3, Twist, CD158\u00a0k\/KIR3DL2, and NKp46 gene expression combination for reliable Sezary syndrome diagnosis. Blood 121(8):1477\u20131478","journal-title":"Blood"},{"issue":"8","key":"2_CR153","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/jid.2015.116","volume":"135","author":"HK Wong","year":"2015","unstructured":"Wong HK, Gibson H, Hake T et al (2015) Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome. J Invest Dermatol. 135(8):2084\u20132092","journal-title":"J Invest Dermatol."},{"issue":"9","key":"2_CR154","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1182\/blood-2014-05-571778","volume":"125","author":"Y Huang","year":"2015","unstructured":"Huang Y, Su MW, Jiang X, Zhou Y (2015) Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma. Blood 125(9):1435\u20131443","journal-title":"Blood"},{"key":"2_CR155","doi-asserted-by":"crossref","unstructured":"Dulmage BO, Akilov O, Vu JR, Falo LD, Geskin LJ (2015) Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma. Oncotarget","DOI":"10.18632\/oncotarget.5742"},{"issue":"11","key":"2_CR156","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.jid.2016.05.126","volume":"136","author":"A Haider","year":"2016","unstructured":"Haider A, Steininger A, Ullmann R et al (2016) Inactivation of RUNX3\/p46 Promotes Cutaneous T-Cell Lymphoma. J Invest Dermatol. 136(11):2287\u20132296","journal-title":"J Invest Dermatol."},{"issue":"9","key":"2_CR157","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","volume":"47","author":"J Choi","year":"2015","unstructured":"Choi J, Goh G, Walradt T et al (2015) Genomic landscape of cutaneous T cell lymphoma. Nat Genet 47(9):1011\u20131019","journal-title":"Nat Genet"},{"issue":"12","key":"2_CR158","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","volume":"47","author":"AC Silva Almeida da","year":"2015","unstructured":"da Silva Almeida AC, Abate F, Khiabanian H et al (2015) The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome. Nat Genet 47(12):1465\u20131470","journal-title":"Nat Genet"},{"key":"2_CR159","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","volume":"6","author":"MJ Kiel","year":"2015","unstructured":"Kiel MJ, Sahasrabuddhe AA, Rolland DC et al (2015) Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome. Nat Commun. 6:8470","journal-title":"Nat Commun."},{"issue":"12","key":"2_CR160","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","volume":"47","author":"L Wang","year":"2015","unstructured":"Wang L, Ni X, Covington KR et al (2015) Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet 47(12):1426\u20131434","journal-title":"Nat Genet"},{"issue":"2","key":"2_CR161","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ng.3744","volume":"49","author":"R Mathur","year":"2017","unstructured":"Mathur R, Alver BH, San Roman AK et al (2017) ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet 49(2):296\u2013302","journal-title":"Nat Genet"},{"issue":"9","key":"2_CR162","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-13-3608","volume":"74","author":"R Watanabe","year":"2014","unstructured":"Watanabe R, Ui A, Kanno S et al (2014) SWI\/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. Cancer Res 74(9):2465\u20132475","journal-title":"Cancer Res"},{"key":"2_CR163","doi-asserted-by":"crossref","first-page":"13837","DOI":"10.1038\/ncomms13837","volume":"7","author":"CT Williamson","year":"2016","unstructured":"Williamson CT, Miller R, Pemberton HN et al (2016) ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A. Nat Commun. 7:13837","journal-title":"Nat Commun."},{"issue":"11","key":"2_CR164","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.18632\/oncotarget.1555","volume":"4","author":"C Guo","year":"2013","unstructured":"Guo C, Chen LH, Huang Y et al (2013) KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation. Oncotarget. 4(11):2144\u20132153","journal-title":"Oncotarget."},{"issue":"3","key":"2_CR165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2013.07.010","volume":"51","author":"MU Kaikkonen","year":"2013","unstructured":"Kaikkonen MU, Spann NJ, Heinz S et al (2013) Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell 51(3):310\u2013325","journal-title":"Mol Cell"},{"issue":"2","key":"2_CR166","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2008-01-131185","volume":"112","author":"T Hidaka","year":"2008","unstructured":"Hidaka T, Nakahata S, Hatakeyama K et al (2008) Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia\/lymphoma. Blood 112(2):383\u2013393","journal-title":"Blood"},{"issue":"3","key":"2_CR167","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1042\/BJ20091578","volume":"427","author":"V Papadopoulou","year":"2010","unstructured":"Papadopoulou V, Postigo A, Sanchez-Tillo E, Porter AC, Wagner SD (2010) ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus. Biochem J 427(3):541\u2013550","journal-title":"Biochem J"},{"issue":"3","key":"2_CR168","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/intimm\/dxn143","volume":"21","author":"J Wang","year":"2009","unstructured":"Wang J, Lee S, Teh CE, Bunting K, Ma L, Shannon MF (2009) The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. Int Immunol 21(3):227\u2013235","journal-title":"Int Immunol"},{"issue":"11","key":"2_CR169","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood.V84.11.3850.bloodjournal84113850","volume":"84","author":"A Migliazza","year":"1994","unstructured":"Migliazza A, Lombardi L, Rocchi M et al (1994) Heterogeneous chromosomal aberrations generate 3\u2019 truncations of the NFKB2\/lyt-10 gene in lymphoid malignancies. Blood 84(11):3850\u20133860","journal-title":"Blood"},{"issue":"1\u20132","key":"2_CR170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10428199609054800","volume":"23","author":"A Neri","year":"1996","unstructured":"Neri A, Fracchiolla NS, Migliazza A, Trecca D, Lombardi L (1996) The involvement of the candidate proto-oncogene NFKB2\/lyt-10 in lymphoid malignancies. Leuk Lymphoma 23(1\u20132):43\u201348","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2_CR171","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","volume":"47","author":"A Ungewickell","year":"2015","unstructured":"Ungewickell A, Bhaduri A, Rios E et al (2015) Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2. Nat Genet 47(9):1056\u20131060","journal-title":"Nat Genet"},{"issue":"22","key":"2_CR172","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","volume":"118","author":"U Ralfkiaer","year":"2011","unstructured":"Ralfkiaer U, Hagedorn PH, Bangsgaard N et al (2011) Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 118(22):5891\u20135900","journal-title":"Blood"},{"issue":"4","key":"2_CR173","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/jid.2014.487","volume":"135","author":"J Sandoval","year":"2015","unstructured":"Sandoval J, Diaz-Lagares A, Salgado R et al (2015) MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma. J Invest Dermatol. 135(4):1128\u20131137","journal-title":"J Invest Dermatol."},{"issue":"12","key":"2_CR174","first-page":"7207","volume":"34","author":"U Ralfkiaer","year":"2014","unstructured":"Ralfkiaer U, Lindahl LM, Litman T et al (2014) MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Anticancer Res 34(12):7207\u20137217","journal-title":"Anticancer Res"},{"key":"2_CR175","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","volume":"2","author":"MG Narducci","year":"2011","unstructured":"Narducci MG, Arcelli D, Picchio MC et al (2011) MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome. Cell Death Dis 2:e151","journal-title":"Cell Death Dis"},{"issue":"10","key":"2_CR176","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10552-008-9184-z","volume":"19","author":"JD Carreon","year":"2008","unstructured":"Carreon JD, Morton LM, Devesa SS et al (2008) Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer Causes Control 19(10):1171\u20131181","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2_CR177","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107(1):265\u2013276","journal-title":"Blood"},{"issue":"12","key":"2_CR178","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","volume":"89","author":"JK Chan","year":"1997","unstructured":"Chan JK, Sin VC, Wong KF et al (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89(12):4501\u20134513","journal-title":"Blood"},{"issue":"4","key":"2_CR179","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000040955","volume":"101","author":"S Matano","year":"1999","unstructured":"Matano S, Nakamura S, Nakamura S et al (1999) Monomorphic agranular natural killer cell lymphoma\/leukemia with no Epstein-Barr virus association. Acta Haematol 101(4):206\u2013208","journal-title":"Acta Haematol"},{"issue":"5","key":"2_CR180","first-page":"467","volume":"8","author":"AR Martin","year":"1995","unstructured":"Martin AR, Chan WC, Perry DA, Greiner TC, Weisenburger DD (1995) Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol 8(5):467\u2013472","journal-title":"Mod Pathol"},{"issue":"5","key":"2_CR181","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/sj.leu.2401769","volume":"14","author":"M Yagita","year":"2000","unstructured":"Yagita M, Huang CL, Umehara H et al (2000) A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 14(5):922\u2013930","journal-title":"Leukemia"},{"issue":"3","key":"2_CR182","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0145-2126(03)00254-6","volume":"28","author":"IM Chen","year":"2004","unstructured":"Chen IM, Whalen M, Bankhurst A et al (2004) A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization. Leuk Res 28(3):275\u2013284","journal-title":"Leuk Res"},{"issue":"20","key":"2_CR183","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.1073\/pnas.95.20.11963","volume":"95","author":"W Kulwichit","year":"1998","unstructured":"Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N (1998) Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A. 95(20):11963\u201311968","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"2_CR184","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.virol.2009.01.006","volume":"386","author":"ZL Pratt","year":"2009","unstructured":"Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B (2009) The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386(2):387\u2013397","journal-title":"Virology"},{"key":"2_CR185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.02.002","volume":"26","author":"O Klinke","year":"2014","unstructured":"Klinke O, Feederle R, Delecluse HJ (2014) Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol 26:52\u201359","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"2_CR186","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/onc.2013.71","volume":"33","author":"DT Vereide","year":"2014","unstructured":"Vereide DT, Seto E, Chiu YF et al (2014) Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 33(10):1258\u20131264","journal-title":"Oncogene"},{"issue":"4","key":"2_CR187","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ajpath.2013.12.024","volume":"184","author":"WT Huang","year":"2014","unstructured":"Huang WT, Lin CW (2014) EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-gamma-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma. Am J Pathol 184(4):1185\u20131197","journal-title":"Am J Pathol"},{"issue":"8","key":"2_CR188","doi-asserted-by":"crossref","first-page":"e42193","DOI":"10.1371\/journal.pone.0042193","volume":"7","author":"N Motsch","year":"2012","unstructured":"Motsch N, Alles J, Imig J et al (2012) MicroRNA profiling of Epstein-Barr virus-associated NK\/T-cell lymphomas by deep sequencing. PLoS ONE 7(8):e42193","journal-title":"PLoS ONE"},{"issue":"6","key":"2_CR189","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal J, Kucuk C, Deleeuw RJ et al (2009) Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 23(6):1139\u20131151","journal-title":"Leukemia"},{"issue":"6","key":"2_CR190","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, de Reynies A, de Leval L et al (2010) Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood 115(6):1226\u20131237","journal-title":"Blood"},{"issue":"3","key":"2_CR191","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","volume":"44","author":"Y Nakashima","year":"2005","unstructured":"Nakashima Y, Tagawa H, Suzuki R et al (2005) Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 44(3):247\u2013255","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"2_CR192","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","volume":"157","author":"LL Siu","year":"2000","unstructured":"Siu LL, Chan V, Chan JK, Wong KF, Liang R, Kwong YL (2000) Consistent patterns of allelic loss in natural killer cell lymphoma. Am J Pathol 157(6):1803\u20131809","journal-title":"Am J Pathol"},{"issue":"5","key":"2_CR193","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","volume":"155","author":"LL Siu","year":"1999","unstructured":"Siu LL, Wong KF, Chan JK, Kwong YL (1999) Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations. Am J Pathol 155(5):1419\u20131425","journal-title":"Am J Pathol"},{"issue":"2","key":"2_CR194","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cyto.1069","volume":"46","author":"YH Ko","year":"2001","unstructured":"Ko YH, Choi KE, Han JH, Kim JM, Ree HJ (2001) Comparative genomic hybridization study of nasal-type NK\/T-cell lymphoma. Cytometry 46(2):85\u201391","journal-title":"Cytometry"},{"issue":"50","key":"2_CR195","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","volume":"108","author":"C Kucuk","year":"2011","unstructured":"Kucuk C, Iqbal J, Hu X et al (2011) PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci USA 108(50):20119\u201320124","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2_CR196","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube K, Nakagawa M, Tsuzuki S et al (2011) Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 118(12):3195\u20133204","journal-title":"Blood"},{"issue":"1","key":"2_CR197","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajpath.2012.09.012","volume":"182","author":"C Kucuk","year":"2013","unstructured":"Kucuk C, Hu X, Iqbal J et al (2013) HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms. Am J Pathol 182(1):49\u201355","journal-title":"Am J Pathol"},{"issue":"9","key":"2_CR198","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm1621","volume":"13","author":"L Zhang","year":"2007","unstructured":"Zhang L, Anglesio MS, O\u2019Sullivan M et al (2007) The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat Med 13(9):1060\u20131069","journal-title":"Nat Med"},{"issue":"6","key":"2_CR199","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","volume":"159","author":"L Quintanilla-Martinez","year":"2001","unstructured":"Quintanilla-Martinez L, Kremer M, Keller G et al (2001) p53 Mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Am J Pathol 159(6):2095\u20132105","journal-title":"Am J Pathol"},{"issue":"9","key":"2_CR200","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/v4091537","volume":"4","author":"L Frappier","year":"2012","unstructured":"Frappier L (2012) Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses. 4(9):1537\u20131547","journal-title":"Viruses."},{"issue":"6881","key":"2_CR201","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","volume":"416","author":"M Li","year":"2002","unstructured":"Li M, Chen D, Shiloh A et al (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416(6881):648\u2013653","journal-title":"Nature"},{"issue":"1","key":"2_CR202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2005.02.029","volume":"18","author":"V Saridakis","year":"2005","unstructured":"Saridakis V, Sheng Y, Sarkari F et al (2005) Structure of the p53 binding domain of HAUSP\/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell 18(1):25\u201336","journal-title":"Mol Cell"},{"issue":"22","key":"2_CR203","first-page":"6390","volume":"62","author":"T Oka","year":"2002","unstructured":"Oka T, Ouchida M, Koyama M et al (2002) Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias\/lymphomas. Cancer Res 62(22):6390\u20136394","journal-title":"Cancer Res"},{"issue":"1","key":"2_CR204","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9440(10)64349-0","volume":"160","author":"LL Siu","year":"2002","unstructured":"Siu LL, Chan JK, Wong KF, Kwong YL (2002) Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol 160(1):59\u201366","journal-title":"Am J Pathol"},{"issue":"36","key":"2_CR205","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1038\/sj.onc.1210337","volume":"26","author":"MP Deyoung","year":"2007","unstructured":"Deyoung MP, Ellisen LW (2007) p63 and p73 in human cancer: defining the network. Oncogene 26(36):5169\u20135183","journal-title":"Oncogene"},{"issue":"6","key":"2_CR206","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/humu.22523","volume":"35","author":"E Candi","year":"2014","unstructured":"Candi E, Agostini M, Melino G, Bernassola F (2014) How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors. Hum Mutat 35(6):702\u2013714","journal-title":"Hum Mutat"},{"issue":"5","key":"2_CR207","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","volume":"9","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9(5):495\u2013502","journal-title":"Nat Immunol"},{"issue":"9","key":"2_CR208","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/sj.leu.2404323","volume":"20","author":"Y Han","year":"2006","unstructured":"Han Y, Amin HM, Frantz C et al (2006) Restoration of shp1 expression by 5-AZA-2\u2019-deoxycytidine is associated with downregulation of JAK3\/STAT3 signaling in ALK-positive anaplastic large cell lymphoma. Leukemia 20(9):1602\u20131609","journal-title":"Leukemia"},{"issue":"12","key":"2_CR209","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Fung TK, Cheung WC, Liang R, Kwong YL (2004) SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway. Blood 103(12):4630\u20134635","journal-title":"Blood"},{"issue":"1","key":"2_CR210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2012.03.023","volume":"321","author":"KF Chen","year":"2012","unstructured":"Chen KF, Su JC, Liu CY et al (2012) A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation. Cancer Lett 321(1):27\u201335","journal-title":"Cancer Lett"},{"issue":"4","key":"2_CR211","doi-asserted-by":"crossref","first-page":"e10290","DOI":"10.1371\/journal.pone.0010290","volume":"5","author":"DJ Kim","year":"2010","unstructured":"Kim DJ, Tremblay ML, Digiovanni J (2010) Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation. PLoS ONE 5(4):e10290","journal-title":"PLoS ONE"},{"issue":"7","key":"2_CR212","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bcp.2012.12.018","volume":"85","author":"SC Gupta","year":"2013","unstructured":"Gupta SC, Phromnoi K, Aggarwal BB (2013) Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1. Biochem Pharmacol 85(7):898\u2013912","journal-title":"Biochem Pharmacol"},{"key":"2_CR213","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C Kucuk","year":"2015","unstructured":"Kucuk C, Jiang B, Hu X et al (2015) Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat Commun. 6:6025","journal-title":"Nat Commun."},{"issue":"30","key":"2_CR214","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/sj.onc.1205571","volume":"21","author":"T Takakuwa","year":"2002","unstructured":"Takakuwa T, Dong Z, Nakatsuka S et al (2002) Frequent mutations of Fas gene in nasal NK\/T cell lymphoma. Oncogene 21(30):4702\u20134705","journal-title":"Oncogene"},{"issue":"6","key":"2_CR215","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)64490-2","volume":"161","author":"L Shen","year":"2002","unstructured":"Shen L, Liang AC, Lu L et al (2002) Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer\/T-cell lymphoma. Am J Pathol 161(6):2123\u20132131","journal-title":"Am J Pathol"},{"issue":"9","key":"2_CR216","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","volume":"23","author":"P Coppo","year":"2009","unstructured":"Coppo P, Gouilleux-Gruart V, Huang Y et al (2009) STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma. Leukemia 23(9):1667\u20131678","journal-title":"Leukemia"},{"issue":"1","key":"2_CR217","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","volume":"7","author":"H Yu","year":"2007","unstructured":"Yu H, Kortylewski M, Pardoll D (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7(1):41\u201351","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2_CR218","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798\u2013809","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2_CR219","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","volume":"10","author":"T Wang","year":"2004","unstructured":"Wang T, Niu G, Kortylewski M et al (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10(1):48\u201354","journal-title":"Nat Med"},{"issue":"7","key":"2_CR220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","volume":"2","author":"GC Koo","year":"2012","unstructured":"Koo GC, Tan SY, Tang T et al (2012) Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma. Cancer Discov 2(7):591\u2013597","journal-title":"Cancer Discov"},{"issue":"2","key":"2_CR221","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/leu.2013.157","volume":"28","author":"A Bouchekioua","year":"2014","unstructured":"Bouchekioua A, Scourzic L, de Wever O et al (2014) JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. Leukemia 28(2):338\u2013348","journal-title":"Leukemia"},{"issue":"4","key":"2_CR222","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2013.819577","volume":"55","author":"H Kimura","year":"2014","unstructured":"Kimura H, Karube K, Ito Y et al (2014) Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan. Leuk Lymphoma 55(4):962\u2013963","journal-title":"Leuk Lymphoma"},{"key":"2_CR223","doi-asserted-by":"crossref","unstructured":"Jiang L, Gu ZH, Yan ZX, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nature genetics. 2015:Epub ahead of print","DOI":"10.1038\/ng.3358"},{"issue":"5","key":"2_CR224","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","volume":"55","author":"A Dobashi","year":"2016","unstructured":"Dobashi A, Tsuyama N, Asaka R et al (2016) Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type. Genes Chromosomes Cancer 55(5):460\u2013471","journal-title":"Genes Chromosomes Cancer"},{"issue":"19","key":"2_CR225","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","volume":"6","author":"S Lee","year":"2015","unstructured":"Lee S, Park HY, Kang SY et al (2015) Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type. Oncotarget. 6(19):17764\u201317776","journal-title":"Oncotarget."},{"issue":"5","key":"2_CR226","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2008-07-166363","volume":"113","author":"K Miyazaki","year":"2009","unstructured":"Miyazaki K, Yamaguchi M, Imai H et al (2009) Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma. Blood 113(5):1071\u20131074","journal-title":"Blood"},{"issue":"24","key":"2_CR227","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","volume":"119","author":"M Travert","year":"2012","unstructured":"Travert M, Huang Y, de Leval L et al (2012) Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood 119(24):5795\u20135806","journal-title":"Blood"},{"key":"2_CR228","doi-asserted-by":"crossref","unstructured":"Moffitt AB, Ondrejka SL, McKinney M et al (2017) Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med","DOI":"10.1084\/jem.20160894"},{"issue":"12","key":"2_CR229","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","volume":"194","author":"RE Davis","year":"2001","unstructured":"Davis RE, Brown KD, Siebenlist U, Staudt LM (2001) Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194(12):1861\u20131874","journal-title":"J Exp Med"},{"issue":"7074","key":"2_CR230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","volume":"439","author":"AH Bild","year":"2006","unstructured":"Bild AH, Yao G, Chang JT et al (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439(7074):353\u2013357","journal-title":"Nature"},{"issue":"6","key":"2_CR231","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","volume":"198","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K et al (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198(6):851\u2013862","journal-title":"J Exp Med"},{"issue":"12","key":"2_CR232","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL et al (2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102(12):3871\u20133879","journal-title":"Blood"},{"key":"2_CR233","doi-asserted-by":"crossref","unstructured":"Zinzani PL, Tani M, Musuraca G et al (2006) Phase II study of proteasome inhibitor bortezomib (Velcade\u00ae) in patients with relapsed\/refractory T-cell lymphoma: preliminary results. Blood 108a","DOI":"10.1182\/blood.V108.11.2462.2462"},{"key":"2_CR234","doi-asserted-by":"crossref","unstructured":"Piva R, Ruggeri B, Williams M et al (2007) CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib. Blood","DOI":"10.1182\/blood-2007-07-100651"},{"key":"2_CR235","doi-asserted-by":"crossref","first-page":"690a","DOI":"10.1182\/blood.V110.11.690.690","volume":"110","author":"A Feldman","year":"2007","unstructured":"Feldman A, Sun D, Law M (2007) Syk Tyrosine Kinase is Overexpressed in the Majority of Peripheral T and NK-cell Lymphomas, and Re. Blood 110:690a","journal-title":"Blood"},{"issue":"1","key":"2_CR236","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/leu.2009.198","volume":"24","author":"RA Wilcox","year":"2010","unstructured":"Wilcox RA, Sun DX, Novak A, Dogan A, Ansell SM, Feldman AL (2010) Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin\u2019s lymphoma cell lines. Leukemia 24(1):229\u2013232","journal-title":"Leukemia"},{"issue":"8","key":"2_CR237","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/leu.2014.50","volume":"28","author":"PP Piccaluga","year":"2014","unstructured":"Piccaluga PP, Rossi M, Agostinelli C et al (2014) Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. Leukemia 28(8):1687\u20131697","journal-title":"Leukemia"},{"issue":"10","key":"2_CR238","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","volume":"22","author":"J Andrae","year":"2008","unstructured":"Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276\u20131312","journal-title":"Genes Dev"},{"issue":"9","key":"2_CR239","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3109\/10428194.2011.584254","volume":"52","author":"AM Perry","year":"2011","unstructured":"Perry AM, Molina-Kirsch H, Nathwani BN et al (2011) Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system. Leuk Lymphoma 52(9):1681\u20131688","journal-title":"Leuk Lymphoma"},{"key":"2_CR240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.coi.2015.08.001","volume":"37","author":"C Wang","year":"2015","unstructured":"Wang C, Collins M, Kuchroo VK (2015) Effector T cell differentiation: are master regulators of effector T cells still the masters? Curr Opin Immunol 37:6\u201310","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2_CR241","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR et al (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 13(1):140\u2013149","journal-title":"Ann Oncol"},{"issue":"25","key":"2_CR242","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"Vose J, Armitage J, Weisenburger D, International TCLP","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol"}],"container-title":["Cancer Treatment and Research","T-Cell and NK-Cell Lymphomas"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-99716-2_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T21:58:36Z","timestamp":1605909516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-99716-2_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"ISBN":["9783319997155","9783319997162"],"references-count":242,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-99716-2_2","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}